Moolec Science (NASDAQ:MLEC) Announces Quarterly Earnings Results

Moolec Science (NASDAQ:MLEC) issued its earnings results on Thursday. The company reported $47.49 EPS for the quarter, FiscalAI reports. The firm had revenue of $2.62 million during the quarter.

Moolec Science Stock Up 5.3%

Shares of NASDAQ:MLEC traded up $0.45 during midday trading on Friday, reaching $8.93. 95,061 shares of the company were exchanged, compared to its average volume of 206,033. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $142.05. The stock has a fifty day simple moving average of $8.42 and a two-hundred day simple moving average of $7.69. The firm has a market cap of $6.48 million, a PE ratio of -0.27 and a beta of 0.38.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Moolec Science from a “sell” rating to a “hold” rating in a research note on Saturday.

Institutional Investors Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC bought a new stake in Moolec Science SA (NASDAQ:MLEC) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science at the end of the most recent quarter. 0.07% of the stock is currently owned by institutional investors and hedge funds.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.